Among lymphocyte subsets, the percentage of CD4+ Tregs was a more sensitive biomarker to predict the prognosis of stroke and influence treatment strategies, and it had independent predictive ability for admission, discharge and neurological function at 3 months.50 The gene discussed is CD4; the disease is stroke disorder.